-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-standardized-library_0.pdf
February 01, 2019 - : exercise,
weight loss, compression
stockings
Medications include: coumarins
(α-benzopyrenes), flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-standardized-library.pdf
February 01, 2019 - : exercise,
weight loss, compression
stockings
Medications include: coumarins
(α-benzopyrenes), flavonoids
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/comments/lecvd-comments.pdf
April 01, 2017 - Peer Reviewer #2 Methods Medical treatment methods should have included
venoactive agents, such as flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plant-based-chronic-pain-review-q3.pdf
September 01, 2021 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-appendixes.pdf
April 01, 2022 - tetrahydrocannabinol, cannabidiol, terpenes, flavonoids), and specific formulations used
• Co-use of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
January 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
February 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0.pdf
March 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3.pdf
May 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
January 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
March 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-surveillance-report-3.pdf
May 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-appendices.pdf
January 16, 2023 - tetrahydrocannabinol, cannabidiol, terpenes, flavonoids), and specific formulations used
• Co-use of